Linezolid
Formulations: - Oral > Solid > dispersible tablet: 150 mg (scored) Oral > Solid > tablet: 600 mg - Parenteral > General injections > IV: 2 mg per mL in 300 mL bag Oral > Liquid: 100 mg per 5 mL powder for oral liquid Oral > Solid: 400 mg tablet; 600 mg tablet Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 600 mg Indications: - Multi-drug resistant Mycobacterium tuberculosis - Other specified bacterial diseases - Methicillin resistant Staphylococcus aureus - Vancomycin resistant Staphylococcus aureus - Vancomycin resistant Enterococcus Source: EML workbook import
